septembre 22, 2025 - septembre 23, 2025
Connect with us at CAPT's Annual Conference 2025
MaRS Discovery District | 101 College St, Toronto, ON M5G 0A3
Day 1 - 2:00 PM - 3:00 PM
Maximizing the Value of PSP Data for Decision Making
Patient support programs (PSPs) are an integral part of a patient journey. They focus on enhancing care for patients with complex medical conditions treated with specialty medications, and the programs work in tandem with the healthcare system to fill the gaps in these patients’ disease management needs.
There is broad recognition by various stakeholders of the opportunity to leverage PSPs for RWE generation due to the multiple touchpoints with patients and direct communication with patients’ healthcare teams and physicians, payers, and caregivers.
With PSP infrastructure well-entrenched in Canada and building on the capability of PSPs to collect pan-Canadian data, an initiative led by the Canadian Personalized Healthcare Innovation Network (CPHIN) has focused on elevating PSP into a robust source of RWE for decision making. The first milestone of this collaborative effort was completed recently with the successful publication of a white paper outlining the “PSP Real World Readiness Framework”.
This session will present an update on progress by the CPHIN team since the publication of the PSP framework. This will be followed by perspectives from the panelists made up of various healthcare system stakeholders; discussions will include how organizations can best apply the PSP framework to improve the quality of PSP data.
Alison Oliver
Senior Director, Customer Experience
Historically, as a leader of Innomar’s consulting services team, Alison focused on the areas of strategic consulting, market access, and real-world evidence. Today, Alison’s expertise is being leveraged within her current role with patient support programs (PSPs), where she oversees Innomar’s rare disease portfolio.
Belinda Yap, MPH, PhD
Director, HEOR
Belinda brings a wealth of expertise in outcomes research, complex modelling and evidence generation to her current role. She leads a team of HEOR specialists in addressing the most critical reimbursement challenges confronting new therapies today. Belinda’s successful record in leading numerous highly challenging files is a testament to her ability to create innovative HEOR and RWE solutions.
Belinda obtained her MPH in Healthcare Management (Columbia University), her Ph.D. in Health Sciences and Technology (Harvard Medical School and Massachusetts Institute of Technology), and completed her post-doctoral training at the Brigham and Women’s Hospital (Boston). Prior to her role at Innomar, Belinda worked at the Programs for Assessment of Technology in Health (PATH), McMaster University. At PATH, she designed and managed large multi-center clinical studies and applied specialized knowledge and scientific principles in support of a variety of health technology assessment (HTA) projects for both public and private sectors, including reimbursement of new drugs in Canada. She also has extensive experience developing and maintaining relationships with Canadian Key Opinion Leaders (KOLs).
Patient support programs: A significant source of real-world data
Meet the team
Your questions, answered.
Let's Connect at the CAPT Annual Conference
Our team will be on location to meet with you. Schedule time to connect with our experts while attending the CAPT Annual Conference to learn how our expert insights can guide your business decisions.
